APPLICATIONS PUBLISHED 5 FEBRUARY 2003
Published: 1-Aug-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Delivery systems for treatment of vascular disease
Cordis 1280512*
Subcutaneous access port
Alphaport 1280513*
Pharmaceutical compsns comprising cannabis
GW Pharma 1280515*
Method for transdermal or intradermal delivery of molecules
Health Research 1280516*
Beta-glucans encapsulated in liposomes
MCP Hahneman 1280517*
Liposome drug delivery
Enzrel 1280518*
Microprojectile delivery system and particulate product
Psimedica 1280519*
Phospholipid-based powders for drug delivery
Alliance Pharmaceutical Corp 1280520*
Vaccine compsn, method of preparing the same, and method of vaccinating vertebrates
Pharmacia & Upjohn 1280521*
Combination of carboxylalkylethers with antihypertensives and pharmaceutical use
Warner-Lambert 1280522*
Use of benzimide derivatives for the treatment of high occular tension and glaucoma
Sucampo; Fujisawa Pharmaceutical 1280523*
Methods and compsns for modulating alpha adrenergic receptor activity
Allergan 1280524*
Methods and compsns for modulating alpha adrenergic receptor activity
Allergan 1280525*
Compsn for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth
Universitair Medisch Centrum Utrecht 1280526*
Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
Pharmacia Italia 1280527*
R-eliprodil for treating glaucoma
Alcon 1280528*
Opioid antagonist containing compsn for enhancing the potency or reducing adverse side effects of opioid agonists
Pain Therapeutics; Albert Einstein College of Medicine of Yeshiva University 1280529*
Treatment of fibromyalgia and chronic fatigue syndrome
Pharmacia & Upjohn 1280530*
Local anaesthetic methods and kits
Novalar Pharmaceuticals 1280531*
Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
Chiesi Farmaceutici 1280532*
Aldosterone antagonist compsn for release during aldosterone acrophase
Pharmacia 1280533*
Torasemide-containing pharmaceutical preparations
Abbott Laboratories 1280534*
Processes for preparing clarithromycin polymorphs
Teva Pharmaceutical Industries 1280535*
Method for treating retinal degeneration with purinergic receptor agonists
Inspire Pharmaceuticals 1280536*
Compsns of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof
Supratek Pharma; Kabanov, Alexander 1280537*
Compsns containing molecular iodine
Ben Gurion University of the Negev Research and Development Authority 1280538*
Nontoxic vernix compsns and method of producing
Children's Hospital Research Foundation 1280539*
Modified factor VIII
Emory University 1280540*
Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
Institut National de la Recherche Agronomique 1280541*
Use of a cell extract of at least a plant of the family Pontederiaceae as an anti-pollution agent
L'Oreal 1280542*
Process for producing, methods and compsns of glucuronoxylomannan as nutraceutical agent from higher basidiomycetes mushroom
Medmyco; Wasser, Solomon; Reshetnikov, Sergey 1280543*
Hyaluronidase activity and allergenic cell activity inhibitor
Tsukuba Biosystem 1280544*
Cross-linked collagen matrices and methods for their preparation
Colbar R&D 1280545*
Method and compsn for the treatment of angiogenesis
Children's Medical Centre; Trustees of Boston University 1280546*
Mast cell regulation
Innoventus Project 1280547*
Subcutaneous administration of coagulation factor VII
Novo Nordisk 1280548*
Use of urokinase inhibitors for the treatment and/or prevention of pulmonary hypertension and/or cardiac remodelling
Vlaams Interuniversitair Institut voor Biotechnologie; D Collen Research Foundation 1280549*
Electroporation for introduction of molecules into cells
Electrofect 1280550*
Immunizing against HIV infection
Aventis Pasteur 1280551*
Compsns and methods of treating cancer using compsns comprising an inhibitor of endothelin receptor activity
California Institute of Technology 1280552*
Methods of affecting laminin 5 processing
Fibrogen; The Board of Trustees of the Leland Stanford Junior University 1280553*
A pharmaceutical compsn and method of treatment of diseases of cognitive disfunction in a mammal
Pfizer Products 1280554*
Treatment of congestive heart failure with a compsn comprising a diuretic agent and a vasopressin antagonist
Warner-Lambert 1280555*
Compsns and methods for protecting cells during cancer chemotherapy and radiotherapy
Wisconsin Alumni Research Foundation 1280556*
Method for the preparation of polymeric micelle via phase separation of block copolymer
Samyang 1280557*
Semi-solid delivery vehicle and pharmaceutical compsns
Advanced Polymer Systems 1280558*
Acylated cyclodextrin guest inclusion complexes
Eastman Chemical Company 1280559*
Cationic polymer-nucleic acid complexes and methods of making them
The University of Nottingham 1280560*
